Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew J Peters

Showing results (81-90 of 93) with videos related to

Pageof 10
Sort By:
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Chest|May 21, 2025
Prediction pathway for severe asthma exacerbations: a Bayesian Network analysisChandra Prakash Yadav, Atlanta Chakraborty, David B Price, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
Pageof 10

Showing results (81-90 of 93) with videos related to

Sort By:
Pageof 10
Pragmatic and Observational Research|October 26, 2023
Adult Severe Asthma Registries: A Global and Growing InventoryBreda Cushen, Mariko Siyue Koh, Trung N Tran, et al.
Chest|May 21, 2025
Prediction pathway for severe asthma exacerbations: a Bayesian Network analysisChandra Prakash Yadav, Atlanta Chakraborty, David B Price, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|December 27, 2023
Impact of pre-biologic impairment on meeting domain-specific biologic responder definitions in patients with severe asthmaLuis Perez-de-Llano, Ghislaine Scelo, G Walter Canonica, et al.
Tuberculosis and Respiratory Diseases|February 6, 2025
International Severe Asthma Registry (ISAR): 2017-2024 Status and Progress UpdateDésirée Larenas-Linnemann, Chin Kook Rhee, Alan Altraja, et al.
Allergy|June 26, 2024
Real-world biologics response and super-response in the International Severe Asthma Registry cohortEve Denton, Mark Hew, Matthew J Peters, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 9, 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry"Wenjia Chen, Trung N Tran, Mohsen Sadatsafavi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 3, 2025
Response to biologics along a gradient of T2 involvement in patients with severe asthma: a data-driven biomarker clustering approachEileen Wang, William Henley, Désirée Larenas-Linnemann, et al.
American Journal of Respiratory and Critical Care Medicine|November 28, 2023
Association Between T2-related Comorbidities and Effectiveness of Biologics in Severe AsthmaMichael E Wechsler, Ghislaine Scelo, Désirée E S Larenas-Linnemann, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|August 28, 2023
Analysis of comorbidities and multimorbidity in adult patients in the International Severe Asthma RegistryGhislaine Scelo, Carlos A Torres-Duque, Jorge Maspero, et al.
American Journal of Respiratory and Critical Care Medicine|May 18, 2025
Prevention of Cardiovascular and Other Systemic Adverse Outcomes in Patients with Asthma Treated with BiologicsMohsen Sadatsafavi, Trung N Tran, Ghislaine Scelo, et al.
Pageof 10